Recent Analyst Forecasts and Stock Ratings
4D Molecular Therapeutics Inc FAQ's
4D Molecular Therapeutics Inc has been rated by research analysts at Goldman Sachs, Barclays, Leerink Partners, RBC Capital, Morgan Stanley, BMO Capital in the past 90 days.